Pricing Log in Create free account

Olema Pharmaceuticals, Inc. (OLMA) vs Solid Biosciences Inc. (SLDB)

Olema Pharmaceuticals, Inc. and Solid Biosciences Inc. are both Biotechnology companies. Olema Pharmaceuticals, Inc. and Solid Biosciences Inc. are of similar size ($615.5M and $601.1M). Across the 9 metrics below, Solid Biosciences Inc. leads on 5 and Olema Pharmaceuticals, Inc. on 4.

Valuation

Metric OLMA SLDB Biotechnology median
P/E n/m n/m 8.50
P/S n/m 70.64 9.71
P/B 1.60 2.12 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 37.04 9.21
Earnings yield (32.22%) (34.54%) (33.15%)
Free cash flow yield (24.00%) (23.62%) (25.50%)

Profitability

Metric OLMA SLDB Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (52.74%) (65.50%) (56.36%)
Return on assets (47.10%) (56.83%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric OLMA SLDB Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 15.00% 34.97% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric OLMA SLDB Biotechnology median
Debt to equity 0.01 0.00 0.00
Current ratio 8.86 13.82 4.72
Net debt to EBITDA 2.82 1.05 0.96

Dividend

Metric OLMA SLDB Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric OLMA SLDB Biotechnology median
Market cap 601.10m 615.48m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack